Science Supporting Biosecurity and Pandemic Preparedness

Pandemics, natural or person-made, have the potential to cause significant, and perhaps unprecedented, harm. We support breakthrough research in the basic science of infectious disease, pathogen detection and identification, and countermeasures. We are especially interested in research that applies to a wide swath of pathogen types. Others at Open Philanthropy support policy and governance efforts to reduce these risks.

Our Work

Blog Post 6/2019

We awarded a five-year grant and made an additional investment in Sherlock Biosciences to support the development of a diagnostic platform to quickly, easily, and inexpensively identify any human virus.

Press 5/2021
from The New York Times

In her role at the Broad Institute, Open Philanthropy grantee Pardis Sabeti worked with Colorado Mesa University to develop a system for pandemic management, versions of which may be used to respond to future outbreaks.

placeholder image where no real cover image exists
Grant 3/2021
$100,642

Open Philanthropy recommended a grant to UC Davis to enable Associate Professor Lark L. Coffey to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.

Press 3/2021
from The New York Times

Open Philanthropy grantee Pardis Sabeti helped develop and deploy a pandemic “pre-emption” network that could help track and prevent the spread of future pandemics.

placeholder image where no real cover image exists
Grant 2/2021
$220,553

Open Philanthropy recommended a grant to the Weill Cornell Medical College of Cornell University to enable postdoctoral researcher Ria Goswami and Dr. Sallie Permar to study the effectiveness of an Hsp90 protein inhibitor as a host-directed antiviral against the COVID-19 virus.

Press 2/2021
from The New York Times

Open Philanthropy grantee Michael Mina is working on a worldwide serological observatory that can check blood for the presence of antibodies to hundreds of viruses. The observatory could help track the spread of COVID-19 and future pandemics.

placeholder image where no real cover image exists
Grant 11/2020
$2,000,000

Open Philanthropy recommended an investment in Binx to support work to incorporate Sherlock Biosciences’s COVID-19 assay into Binx’s point-of-care diagnostic platform.

placeholder image where no real cover image exists
Grant 11/2020
$100,000

Open Philanthropy recommended a grant to the 221B Foundation to support a pilot study, led by Jay Mahat, of a COVID-19 assay in Nepal.

Pages